- CA$483.76m
- CA$480.29m
- CA$174.97m
- 26
- 54
- 66
- 47
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.94 | ||
| Price to Tang. Book | 1.11 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.81 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -18.22% | ||
| Return on Equity | -23.26% | ||
| Operating Margin | -48.45% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 245.54 | 268.7 | 245.25 | 221.34 | 174.97 | 272.96 | 320.3 | 25.95% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.
Directors
- Ronald Funk NEC (64)
- Miguel Martin CEO (49)
- Glen Ibbott CFO
- Andre Jerome EVP
- Carey Squires EVP
- Jillian Swainson SEC
- Michael Singer DRC (57)
- Margaret Atkins IND (64)
- Norma Beauchamp IND (60)
- Theresa Firestone IND (66)
- Lance Friedmann IND (66)
- Chitwant Kohli IND
- Adam Szweras IND (49)
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 21st, 2006
- Public Since
- September 26th, 2007
- No. of Employees
- 1,130
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Toronto Stock Exchange- Shares in Issue
- 54,539,376
- Address
- 2207 90B Street Sw, LEDUC, T6X 1V8
- Web
- https://www.auroramj.com/
- Phone
- +1 6043625207
- Auditors
- KPMG LLP
Upcoming Events for ACB
Q1 2025 Aurora Cannabis Inc Earnings Release
Aurora Cannabis Inc Annual Shareholders Meeting
Similar to ACB
Auxly Cannabis
Toronto Stock Exchange
Bausch Health Companies
Toronto Stock Exchange
Canopy Growth
Toronto Stock Exchange
Charlotte's Web Holdings
Toronto Stock Exchange
Cipher Pharmaceuticals
Toronto Stock Exchange
FAQ
What is the Aurora Cannabis share price?
As of Today at 19:03 UTC, shares in Aurora Cannabis are trading at CA$8.87. This share price information is delayed by 15 minutes.
How has the Aurora Cannabis share price performed this year?
Shares in Aurora Cannabis last closed at CA$8.87 and the price had moved by +8.17% over the past 365 days. In terms of relative price strength the Aurora Cannabis share price has outperformed the Toronto Stock Exchange 300 Composite Index by +2.64% over the past year.
What are the analyst and broker recommendations for Aurora Cannabis?
The overall consensus recommendation for Aurora Cannabis is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Aurora Cannabis dividend yield?
Aurora Cannabis does not currently pay a dividend.
Does Aurora Cannabis pay a dividend?
Aurora Cannabis does not currently pay a dividend.
When does Aurora Cannabis next pay dividends?
Aurora Cannabis does not currently pay a dividend.
How do I buy Aurora Cannabis shares?
To buy shares in Aurora Cannabis you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Aurora Cannabis?
As of the previous close price of CA$8.87, shares in Aurora Cannabis had a market capitalisation of CA$483.76m.
Where are Aurora Cannabis shares listed?
Here are the trading details for Aurora Cannabis:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: ACB
What kind of share is Aurora Cannabis?
Based on an overall assessment of its quality, value and momentum Aurora Cannabis is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Aurora Cannabis share price forecast for 2024?
The analyst consensus target price for shares in Aurora Cannabis is CA$7.83. That is 11.72% below the last closing price of CA$8.87.
Analysts covering Aurora Cannabis currently have a consensus Earnings Per Share (EPS) forecast of -CA$1.25 for the next financial year.
What is the trend in the Aurora Cannabis share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aurora Cannabis. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +27%.
As of the last closing price of CA$8.87, shares in Aurora Cannabis were trading +32.55% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Aurora Cannabis PE Ratio?
The Aurora Cannabis PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$8.87.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Aurora Cannabis?
Aurora Cannabis' management team is headed by:
- Ronald Funk - NEC
- Miguel Martin - CEO
- Glen Ibbott - CFO
- Andre Jerome - EVP
- Carey Squires - EVP
- Jillian Swainson - SEC
- Michael Singer - DRC
- Margaret Atkins - IND
- Norma Beauchamp - IND
- Theresa Firestone - IND
- Lance Friedmann - IND
- Chitwant Kohli - IND
- Adam Szweras - IND